63. Immunotherapy Protein Engineering & Entrepreneurship w/ Dane Wittrup - Professor @ MIT
Professor Dane Wittrup attended the University of New Mexico as an undergraduate, graduating Summa Cum Laude with a Bachelors in Chemical Engineering in June, 1984. Wittrup went on to attend the California Institute of Technology in Pasadena, where he worked with Prof. James Bailey on flow cytometr…
Synthetic Biology and Programmable mRNA with Strand Therapeutics' Jake Becraft
We love to hear from our listeners. Send us a message.
Strand Therapeutics' CEO and Co-Founder Jake Becraft joins Erin Harris to discuss genetic regulation and how the company's programmable mRNA constructs combine genes for self-replication derived from RNA viruses with genetically programmed logi…
State of Possible: Strand Therapeutics' Co-Founder & CEO Jake Becraft talks mRNA and getting into the clinic with the company's first program
He describes the intratumoral IL-12 program that is in the clinic today, and the preclinical progress Strand is making on its other programs. Plus, his thoughts on the current public perception of mRNA.
Season 2, Episode 16: Breaking Barriers with Jacob Becraft
Season 2, Episode 16: Breaking Barriers with Jacob BecraftJoin Michael Petrack on the Pharmaverse Podcast as he interviews Jake Becraft, CEO & Co-founder of Strand Therapeutics! Discover how Jake is transforming cancer treatment with programmable mRNA therapies.Hear about his journey from a small t…
Jake Becraft on going all in on mRNA and proving skeptics wrong
Jake Becraft reflects on making bold bets in mRNA, the journey from lab bench to biotech founder, and the state of science today.
(00:00) Introduction to Jake Becraft
(00:39) Betting big on mRNA — before it was a proven modality
(11:34) Getting your drugs to patients
(25:47) The state of modern bio…
Attacking Cancer With Code And Winning - EP 48 Jake Becraft
Jake Becraft was working on mRNA way before it was cool.
In fact, Becraft’s advisors at MIT told him trying to develop therapies with mRNA would be a colossal waste of time. But, here we are in 2025, and Becraft has pushed the mRNA technology that gained so much attention during the pandemic in rat…
#868: Tim’s Founder Kitchen — From Brainstorm to The President’s Office in Two Months (Featuring Jake Becraft, Strand Therapeutics)
Jake Becraft is the CEO and co-founder of Strand Therapeutics, a company building one of the most advanced programmable genetic medicine platforms in biotechnology. Under his leadership, Strand is redefining what RNA medicines can do by enabling cell-selective targeting and therapeutic payload deli…
Episode 192 - August 7, 2026
On this week’s episode, Sam Fazeli, Brian Skorney, Yaron Werber, and Strand Therapeutics CEO Jake Becraft open with the wave of dealmaking and a solid Q2 earnings season, then turn to the reports of the potential AstraZeneca/Bristol Myers merger, which the group called “more smoke than fire.” Next,…
Live from Boston: Has China changed how we build companies?
In a world where promising drugs are quickly copied, improved on and raced into trials, is science still a differentiator? Strand Therapeutics CEO Jake Becraft and Roivant Sciences CEO Matt Gline discussed what actually counts as innovation, and if where the innovation happens matters for how the i…
PODCAST SØGEMOTOR
Du kan bruge vores hjemmeside til at søge efter3,824,033podcasts og195,710,248episoder efter personer, steder eller emner.
En investering i viden giver det bedste afkast, så jeg lytter til podcasts.
‐ Benjamin "Llamacorn" Franklin
REDIG
Tak fordi du hjælper med at holde podcast-databasen opdateret.
